Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of May 2023, specifically dated May 3, 2023. The report addresses the Company's status regarding Nasdaq listing compliance following a deficiency notice received in November 2022 for failing to maintain a minimum bid price of $1.00 per share.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance and listing status rather than financial performance metrics.
Material Changes
- Market Transfer: Effective May 4, 2023, Evogene's ordinary shares were transferred from the Nasdaq Global Market to the Nasdaq Capital Market.
- Compliance Extension: Nasdaq granted the Company an additional 180-day compliance period, extending the deadline to regain compliance with the Bid Price Rule to October 30, 2023.
- Trading Status: Shares continue to trade on the Nasdaq Capital Market under the symbol EVGN without immediate interruption.
Outlook, Risks, and Contingencies
Compliance Requirements: To regain full compliance, the Company must maintain a closing bid price of $1.00 or more for 10 consecutive business days before the October 30, 2023 deadline. Alternatively, the Company may implement a reverse stock split, which must be completed no later than ten business days prior to the expiration of the Extended Compliance Date.
Delisting Risk: If the Company fails to regain compliance by October 30, 2023, Nasdaq will notify the Company that its shares are subject to delisting. While the Company may appeal this determination to a Nasdaq Hearings Panel, there is no assurance that such an appeal would be successful.
Investor Verification Checklist
- Verify the current closing bid price of EVGN shares to assess progress toward the $1.00 threshold.
- Monitor for any announcements regarding a potential reverse stock split before the October 2023 deadline.
- Confirm the continued trading status on the Nasdaq Capital Market.
- Review future filings for updates on the Company's financial position, as this specific filing contains no financial data.